M, C., D, V., A, M., J, C., R, L., G, V., . . . JA, J. (2026). Overcoming resistance in lung cancer: Combined mitochondrial destabilization by lipophilic cations and doxycycline in hypoxic non-small cell lung carcinoma. Frontiers in pharmacology, 17, 1797291. https://doi.org/10.3389/fphar.2026.1797291
Chicago Style (17th ed.) CitationM, Catalán, Vidal D, Molina-Berríos A, Carrasco-Rojas J, López-Muñoz R, Vásquez G, Olmedo I, and Jara JA. "Overcoming Resistance in Lung Cancer: Combined Mitochondrial Destabilization by Lipophilic Cations and Doxycycline in Hypoxic Non-small Cell Lung Carcinoma." Frontiers in Pharmacology 17 (2026): 1797291. https://doi.org/10.3389/fphar.2026.1797291.
MLA (9th ed.) CitationM, Catalán, et al. "Overcoming Resistance in Lung Cancer: Combined Mitochondrial Destabilization by Lipophilic Cations and Doxycycline in Hypoxic Non-small Cell Lung Carcinoma." Frontiers in Pharmacology, vol. 17, 2026, p. 1797291, https://doi.org/10.3389/fphar.2026.1797291.